Strata Critical Medical (SRTA) Depreciation & Amortization (CF) (2021 - 2026)

Strata Critical Medical has disclosed Depreciation & Amortization (CF) across 6 years of filings, most recently posting $3.1 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 80.32% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $9.5 million (up 57.43% YoY), while the FY2025 annual figure was $8.2 million, up 37.29% from the prior year.
• Depreciation & Amortization (CF) improved to $3.1 million in Q1 2026, from $3.0 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for SRTA reached as high as $3.1 million in Q1 2026 and fell as low as $1.1 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.7 million (2025), against an average of $1.9 million.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 808.73% — and 2024, when it plunged 30.6%.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.3 million in 2022, then decreased by 21.48% to $1.8 million in 2023, then fell by 15.28% to $1.5 million in 2024, then soared by 96.6% to $3.0 million in 2025, then grew by 1.73% to $3.1 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.1 million, $3.0 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.